Integra LifeSciences Holdings announced that the results of the NeuraGen Nerve Guide clinical trail been accepted and an abstract will be presented at the January 2011 joint meeting of the American Association for Hand Surgery, American Society for Reconstructive Microsurgery, and American Society for Peripheral Nerve. This was a controlled, randomized, blind, parallel group, multicenter study of peripheral nerve repair comparing the NeuraGen Nerve Guide to direct suture in patients who had complete traumatic nerve injuries to the median and/or ulnar nerves. Thirty-two patients completed the 2-year postoperative follow-up period, during which they were routinely examined for sensory and motor electrophysiological function, post-op pain assessments, and overall hand-function. Results exhibited patients who received the NeuraGen Nerve Guide (a highly-purified, type 1 collagen conduit used in peripheral nerve repair) had lower post-op pain than those treated with direct suture repair. The overall study conclusion was that entubulation nerve repair using the NeuraGen Nerve Guide is as effective a method of joining severed nerves as direct microsurgical suture or short gap graft repair. This showed that the NeuraGen Nerve Guide repair is a realistic alternative to conventional end-to-end or graft repair.
(Source: Vision-Sciences, Globe Newswire, October 7, 2010)
